Articles From: Oclaro to Announce Third Quarter Fiscal Year 2013 Financial Results on Tuesday, May 7, 2013 to Ocwen Financial Corporation Schedules Conference Call - 4th Quarter / Year End 2012 Results


2013/5/2
SAN JOSE, Calif.
Sign-up for Oclaro to Announce Third Quarter Fiscal Year 2013 Financial Results on Tuesday, May 7, 2013 investment picks
2013/2/22
SAN JOSE, Calif.
Sign-up for Oclaro to Present at the Morgan Stanley Technology, Media and Telecom Conference investment picks
2013/2/4
SAN JOSE, Calif.
Sign-up for Oclaro to Present at the Stifel Nicolaus Annual Technology Conference investment picks
2013/1/29
Stronger Product Line-up Addresses a Wide Range of Markets and Features Wavelengths from Violet, Visible to Near-Infrared SAN JOSE, Calif.
Sign-up for Oclaro to Showcase an Expanded Laser Diode Product Portfolio at Photonics West 2013 investment picks
2013/5/8
New fiber-coupled BMU platform delivers higher power and brightness for pumping of kW and high power pulsed fiber lasers SAN JOSE, Calif.
Sign-up for Oclaro Unveils 80 W High Brightness Fiber Laser Pump Module investment picks
2013/3/13
Platform Features a Broad Array of Optical Communications Technologies that Customers Can Choose From to Meet their Performance, Cost, Form Factor and Time-to-Market Requirements SAN JOSE, Calif.
Sign-up for Oclaro Unveils New Customizable Add/Drop Routing Platform for Next Generation Networks investment picks
2013/5/1
Oconee Federal Financial Corp.
Sign-up for Oconee Federal Financial Corp. Announces Three and Nine Month Financial Results investment picks
2013/1/31
Oconee Federal Financial Corp.
Sign-up for Oconee Federal Financial Corp. Announces Three and Six Month Financial Results investment picks
2013/2/25
One of the most recognized names in the financial arena among professional athletes, entertainers and celebrities, Octagon Financial Services (OFS) , has become the most recent independent investment advisory firm to select Dynasty Financial Partners’ open-architecture platform of wealth management services and technology.
Sign-up for Octagon Financial Services, a Specialty Advisory Firm with a Focus on Professional Athletes, Aligns with Dynasty Financial Partners investment picks
2013/5/9
FOUNTAIN VALLEY, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- MEDL Mobile, Inc. (OTCBB:MEDL) – a pioneer in the creation, development, marketing and monetization of mobile apps – announced today that Hang w/ has been chosen to present at the annual VC in the OC Signature event on May 22nd.
Sign-up for OCTANe Selects Hang w/ to Present at the Annual VC in the OC Signature Event investment picks
2013/3/12
PETALUMA, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, devices and nutritional products, today announced the closing of its underwritten public offering of 8,625,000 shares of common stock at an offering price of $0.40 per share, including 1,125,000 shares of its common stock to cover the over-allotment.
Sign-up for Oculus Innovative Sciences Announces Closing of Public Offering of 8,625,000 Shares of Common Stock investment picks
2013/3/14
PETALUMA, Calif., March 14, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, devices and nutritional products, including Microcyn® Technology solutions which are used in multiple markets including dermatology, post-surgical, wound care, and animal healthcare, today announced completion of the 112-day follow-up period in the company's clinical trial for the management of hypertrophic or keloid scars.
Sign-up for Oculus Innovative Sciences Announces Completion of Patient Follow-Up in Scar Management Study investment picks
2013/1/31
PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Announces Fiscal Third Quarter 2013 Financial Results and Conference Call investment picks
2013/4/24
PETALUMA, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, today announced new regulatory approvals in Dubai, United Arab Emirates, Kuwait, and Iraq for three new Microcyn®-based consumer products: Face Cool™, a hydrogel for the treatment of acne and various dermatoses; Baby Cool™, a hydrogel for treatment of baby rash; and Lady Cool™, a feminine hygiene wash.
Sign-up for Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East Countries investment picks
2013/5/1
PETALUMA, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, today announced new regulatory approvals for Microcyn®-based antiseptic products, under the brand name Microdacyn®, in Panama and El Salvador.
Sign-up for Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El Salvador investment picks
2013/3/7
PETALUMA, Calif., March 7, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced the pricing of an underwritten public offering of 7,500,000 shares of its common stock offered at a price to the public of $0.40 per share.
Sign-up for Oculus Innovative Sciences Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock and Intention to Repay Certain Indebtedness investment picks
2013/3/6
PETALUMA, Calif., March 6, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that it intends to offer for sale its common stock in an underwritten public offering.
Sign-up for Oculus Innovative Sciences Announces Proposed Public Offering of Common Stock and Intention to Repay Certain Indebtedness investment picks
2013/3/28
PETALUMA, Calif., March 28, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, announced today that a 1-for-7 reverse split of its common stock will be effective at the open of business on Monday, April 1, 2013.
Sign-up for Oculus Innovative Sciences Announces Reverse Split of Common Stock investment picks
2013/3/20
PETALUMA, Calif., March 20, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today the appointment of John G.
Sign-up for Oculus Innovative Sciences Appoints Jerry McLaughlin to Its Board of Directors investment picks
2013/3/26
PETALUMA, Calif., March 26, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a healthcare company a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, today announced that is has been granted a reclassification of the company's CE Mark for the European formulation Dermacyn™ Wound Care.
Sign-up for Oculus Innovative Sciences Expands Regulatory Claims for Microcyn-Based Advanced Wound Management Products in Europe investment picks
2013/2/13
Oculus board of directors unanimously approved a plan to spin off the company's novel drug RUT58-60 as a separate company to be called Ruthigen, Inc. in January 2013 Oculus' subsidiary, Ruthigen, to pursue a FDA drug indication for U.S. surgical and trauma market (a potential opportunity of over 46 million surgeries annually) and seek partnerships in Europe and Japan Revenue for the third quarter of fiscal 2013 of $3.5 million, up 27% EBITDAS for the third quarter of fiscal 2013 of ($163,000) Revenue for nine months of fiscal 2013 of $12.1 million, up 29% EBITDAS for nine months of fiscal 2013 improved by $2.0 million to ($398,000) with $410,000 of one-time severance costs related to the More Pharma transaction Cash position of $6.6 million at December 31, 2012, up $3.2 million from March 31, 2012 Conference Call Begins at 4:30 p.m. (EST) Today PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.5 Million for the Third Quarter of Fiscal 2013 investment picks
2013/4/4
PETALUMA, Calif., April 4, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, today announced the issuance of three new international patents for the company's flagship technology, Microcyn®. These include a Chinese patent for treatment of second- and third-degree burns, and two Mexican patents, the first for treatment of skin ulcers and the second for treatment of second- and third-degree burns as well.
Sign-up for Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of Three New International Patents for Microcyn(R) Technology investment picks
2013/4/10
PETALUMA, Calif., April 10, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in over 20 countries, today announced that the company's partner in that region, Dyamed Biotech Pte.
Sign-up for Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and Malaysia investment picks
2013/3/7
PETALUMA, Calif., March 7, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced the full exercise of the over-allotment option granted to the representative of the underwriters to purchase an additional 1,125,000 shares of common stock, at a public offering price of $0.40 per share in connection with its previously announced underwritten public offering of 7,500,000 shares of common stock, bringing total gross proceeds from the offering to approximately $3.5 million.
Sign-up for Oculus Innovative Sciences, Inc. Announces Full Exercise of Underwriters' Over-Allotment Option investment picks
2013/4/3
Ocwen Financial Corp.
Sign-up for Ocwen Executive Chairman Received $19.6 Million in 2012 Pay, Mostly Options investment picks
2013/5/2
- Earnings Per Share Increases in Excess of 100% to $0.31 Per Share - ATLANTA, May 2, 2013 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation, (NYSE:OCN) , a leading financial services holding company, today reported Net income of $45.1 million, or $0.31 per share, for the first quarter of 2013 compared to Net income of $19.3 million, or $0.14 per share, for the first quarter of 2012.
Sign-up for Ocwen Financial Announces Operating Results for First Quarter 2013 investment picks
2013/2/28
- Significantly Increases Earnings to $0.47 Per Share in the Fourth Quarter - ATLANTA, Feb.
Sign-up for Ocwen Financial Announces Operating Results for Fourth Quarter and Full Year 2012 investment picks
2013/4/3
ATLANTA, April 3, 2013 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE:OCN) ("Ocwen"), a leading financial services holding company, announced today that it has completed the purchase of Liberty Home Equity Solutions ("Liberty") from Genworth Financial (NYSE:GNW) .
Sign-up for Ocwen Financial Corporation Purchases Liberty Home Equity Solutions investment picks
2013/2/8
ATLANTA, Feb.
Sign-up for Ocwen Financial Corporation Schedules Conference Call - 4th Quarter / Year End 2012 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oclaro to Announce Third Quarter Fiscal Year 2013 Financial Results on Tuesday, May 7, 2013 to Ocwen Financial Corporation Schedules Conference Call - 4th Quarter / Year End 2012 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity